Literature DB >> 13600

The amnesic action of diazepam, flunitrazepam and lorazepam in man.

J W Dundee, K A George.   

Abstract

Studies in man show that it is possible to reliably study the incidence, degree and duration of amnesia produced by drugs by showing patients 10 postcards and testing their ability to recall or recognise them six hours later. Using this method of study it was found that 1 mg flunitrazepam produced a comparable degree of amnesia to 10 mg diazepam, although its action was slightly longer. This difference was more marked when double doses were studied. The onset of the amnesic action of both drugs occurred within 2 minutes of their intravenous injection and rarely persisted for more than 10-15 minutes. In contrast, with 4 mg lorazepam the onset of amnesia was slower and persisted for up to 270 minutes. This was accompanied by a moderate but not excessive amount of drowsiness. Possible clinical uses for such a drug deserve serious consideration.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 13600

Source DB:  PubMed          Journal:  Acta Anaesthesiol Belg        ISSN: 0001-5164


  6 in total

1.  Flumazenil reversal of conscious sedation induced with intravenous fentanyl and diazepam.

Authors:  R L Finder; P A Moore; J M Close
Journal:  Anesth Prog       Date:  1995

Review 2.  Lorazepam: a review of its clinical pharmacological properties and therapeutic uses.

Authors:  B Ameer; D J Greenblatt
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

3.  Effects of triazolam (0.5 mg) on sleep, performance, memory, and arousal threshold.

Authors:  C L Spinweber; L C Johnson
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

4.  Effects of word frequency on recall memory following lorazepam, alcohol, and lorazepam alcohol interaction in healthy volunteers.

Authors:  Sompop Soo-ampon; Noppamars Wongwitdecha; Surin Plasen; Ian Hindmarch; Julia Boyle
Journal:  Psychopharmacology (Berl)       Date:  2004-04-29       Impact factor: 4.530

Review 5.  Pharmaceutical treatment for cognitive deficits in Alzheimer's disease and other neurodegenerative conditions: exploring new territory using traditional tools and established maps.

Authors:  Raymond T Bartus; Reginald L Dean
Journal:  Psychopharmacology (Berl)       Date:  2008-11-15       Impact factor: 4.530

6.  The effects of flurazepam, lorazepam, and triazolam on sleep and memory.

Authors:  T Roth; K M Hartse; P G Saab; P M Piccione; M Kramer
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.